IJROBP Journal SA-CME activity for November 15, 2019 (Volume 105, Issue 4) summarizes potential issues, reviews relevant data and provides guidance for adult patients and their care teams regarding the impact, if any, that genetic testing should have on radiation therapy recommendations.

IJROBP Journal SA-CME activity for November 1, 2019 (Volume 105, Issue 3) helps practitioners to Explore the system of robust  MR data acquisition and processing that is necessary for successful treatment and develop reasonable expectations of the advantages and limitations of MR-only pl

IJROBP Journal SA-CME activity for October 1, 2019 (Volume 105, Issue 2) provides practitioners with an up-to-date summary of recommended palliative regimens incorporating considerations of patient selection, fractionation schemes and treatment modality including SBRT, IMRT and concurren

PRO Journal SA-CME activity for September-October, 2019 (Volume 9, Issue 5) provides practitioners with the knowledge needed to prepare for and recover from a natural disaster.

IJROBP Journal SA-CME activity for September 1, 2019 (Volume 105, Issue 1) provides practitioners with information regarding the techniques of intensity-modulated brachytherapy and its clinical applications. 

IJROBP Journal SA-CME activity for August 1, 2019 (Volume 104, Issue 5) provides practitioners with information on how one institution conducted a phase I/II study for cardiac radioablation ventricular tachycardia. Dosimetric details are provided in this study. 

IJROBP Journal SA-CME activity for July 15, 2019 (Volume 104, Issue 4) provides practitioners with knowledge needed to appropriately select patients for stereotactic body radiotherapy and counsel them regarding efficacy and side effects.

PRO Journal SA-CME activity for July-August, 2019 (Volume 9, Issue 4) will help practitioners to identify planning uncertainties and elements required for unambiguous reporting. 

IJROBP Journal SA-CME activity for March 1, 2015 (Volume 91, Issue 3) investigate the efficacy and toxicity of accelerated hypofractionated thoracic radiotherapy combined with concurrent chemotherapy in the treatment of limited-stage small cell lung cancer.

PRO Journal SA-CME activity for March-April, 2019 (Volume 9, Issue 2) provides practitioners with a review of factors influencing efficacy of radiotherapy in pain response of symptomatic bone metastases.